Veterinary Medicines

Genta-100 EE, 100 mg/ml süstelahus veistele, sigadele ja hobustele

Authorised
  • Gentamicin sulfate
Download as PDF

Product identification

Medicine name:
Genta-100 EE, 100 mg/ml süstelahus veistele, sigadele ja hobustele
Active substance:
  • Gentamicin sulfate
Target species:
  • Cattle
  • Pig
  • Horse (non food-producing)
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Gentamicin sulfate
    153.85
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        192
        day
      • Milk
        7
        day
    • Pig
      • Meat and offal
        146
        day
  • Intravenous use
    • Horse (non food-producing)
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB03
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1487
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 17/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."